Therapeutic efficacy of halocidin-derived peptide HG1 in a mouse model of surgical wound infection with methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 3, 2011, Pages 1296-1299

  Lee, Young Shin ^a   Shin, Yong Pyo ^a   Shin, Seo Hwa ^a   Park, Seungmi ^a   Kim, Myung Hwa ^b   Lee, In Hee ^a  

^a Hoseo University   (South Korea)

^b Dankook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HG1 PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DERMIS; DRUG EFFICACY; DRUG SCREENING; FEMALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INFECTION; SKIN PENETRATION; SURGICAL INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; FEMALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; PEPTIDES; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

EID: 79952340176     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00948-10     Document Type: Article

References (10)

1. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
3. Jang, W. S., et al. 2003. Biological activities of synthetic analogs of halocidin, an antimicrobial peptide from the tunicate Halocynthia aurantium. Antimicrob. Agents Chemother. 47:2481-2486. (Pubitemid 36919448)
4. Jang, W. S., et al. 2006. Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium. FEBS Lett. 580:1490-1496. (Pubitemid 43222020)
5. Jang, W. S., K. N. Kim, Y. S. Lee, M. H. Nam, and I. H. Lee. 2002. Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. FEBS Lett. 521:81-86.
6. McRipley, R. J., and R. R. Whitney. 1976. Characterization and quantitation of experimental surgical wound infections used to evaluate topical antibacterial agents. Antimicrob. Agents Chemother. 10:38-44.
7. Oyston, P. C., M. A. Fox, S. J. Richards, and G. C. Clark. 2009. Novel peptide therapeutics for treatment of infections. J. Med. Microbiol. 58:977-987.
8. Reddy, K. V., R. D. Yedery, and C. Aranha. 2004. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents 24:536-547.
9. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248. (Pubitemid 36098316)
10. Shin, Y. P., et al. 2010. Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases. Antimicrob. Agents Chemother. 54:2855-2866.